New Key Statistics Module, Z-Score and F-Score
OTCPK:SUDFF Key Ratios
Market Cap $ M | 12.07 |
Enterprise Value $ M | 12.81 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 13.18 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 16.50 |
5-y EBITDA Growth Rate % | 34.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -17.06 |
EV-to-EBITDA | -17.14 |
PEG | -- |
Shares Outstanding M | 480.92 |
Net Margin (%) | -48,588.89 |
Operating Margin % | -60,061.11 |
Pre-tax Margin (%) | -48,588.89 |
Quick Ratio | 6.44 |
Current Ratio | 6.44 |
ROA % (ttm) | -108.94 |
ROE % (ttm) | -144.63 |
ROIC % (ttm) | -2,671.58 |
Dividend Yield % | -- |
Altman Z-Score | 33.25 |
SUDFF Number of Guru Trades
SUDFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SUDFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SUDFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arovella Therapeutics Ltd Insider Transactions
No Available Data
News about OTCPK:SUDFF
Total 0- 1